Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP692047.RAvLmS6qkbBdmfjBC6owCcF1ix-l0RMXB84nuLfkAm5Mg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP692047.RAvLmS6qkbBdmfjBC6owCcF1ix-l0RMXB84nuLfkAm5Mg130_assertion type Assertion NP692047.RAvLmS6qkbBdmfjBC6owCcF1ix-l0RMXB84nuLfkAm5Mg130_head.
- NP692047.RAvLmS6qkbBdmfjBC6owCcF1ix-l0RMXB84nuLfkAm5Mg130_assertion description "[Notably, SSX expression in patient tumor samples was restricted to metastatic lesions (5/22; 23%) and no expression was detected in primary prostate tumors examined (0/73; P < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP692047.RAvLmS6qkbBdmfjBC6owCcF1ix-l0RMXB84nuLfkAm5Mg130_provenance.
- NP692047.RAvLmS6qkbBdmfjBC6owCcF1ix-l0RMXB84nuLfkAm5Mg130_assertion evidence source_evidence_literature NP692047.RAvLmS6qkbBdmfjBC6owCcF1ix-l0RMXB84nuLfkAm5Mg130_provenance.
- NP692047.RAvLmS6qkbBdmfjBC6owCcF1ix-l0RMXB84nuLfkAm5Mg130_assertion SIO_000772 21880588 NP692047.RAvLmS6qkbBdmfjBC6owCcF1ix-l0RMXB84nuLfkAm5Mg130_provenance.
- NP692047.RAvLmS6qkbBdmfjBC6owCcF1ix-l0RMXB84nuLfkAm5Mg130_assertion wasDerivedFrom befree-20140225 NP692047.RAvLmS6qkbBdmfjBC6owCcF1ix-l0RMXB84nuLfkAm5Mg130_provenance.
- NP692047.RAvLmS6qkbBdmfjBC6owCcF1ix-l0RMXB84nuLfkAm5Mg130_assertion wasGeneratedBy ECO_0000203 NP692047.RAvLmS6qkbBdmfjBC6owCcF1ix-l0RMXB84nuLfkAm5Mg130_provenance.